BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

692 related articles for article (PubMed ID: 32154934)

  • 21. Fat mass and obesity-associated protein regulates RNA methylation associated with depression-like behavior in mice.
    Liu S; Xiu J; Zhu C; Meng K; Li C; Han R; Du T; Li L; Xu L; Liu R; Zhu W; Shen Y; Xu Q
    Nat Commun; 2021 Nov; 12(1):6937. PubMed ID: 34836959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of Demethylase Genes, FTO and ALKBH1, Is Associated with Prognosis of Gastric Cancer.
    Li Y; Zheng D; Wang F; Xu Y; Yu H; Zhang H
    Dig Dis Sci; 2019 Jun; 64(6):1503-1513. PubMed ID: 30637548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncogenic and Tumor-Suppressive Functions of the RNA Demethylase FTO.
    Zuidhof HR; Calkhoven CF
    Cancer Res; 2022 Jun; 82(12):2201-2212. PubMed ID: 35303057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N6-methyladenosine demethyltransferase FTO-mediated autophagy in malignant development of oral squamous cell carcinoma.
    Wang F; Liao Y; Zhang M; Zhu Y; Wang W; Cai H; Liang J; Song F; Hou C; Huang S; Zhang Y; Wang C; Hou J
    Oncogene; 2021 Jun; 40(22):3885-3898. PubMed ID: 33972683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FTO-mediated autophagy promotes progression of clear cell renal cell carcinoma via regulating SIK2 mRNA stability.
    Xu Y; Zhou J; Li L; Yang W; Zhang Z; Zhang K; Ma K; Xie H; Zhang Z; Cai L; Gong Y; Gong K
    Int J Biol Sci; 2022; 18(15):5943-5962. PubMed ID: 36263177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-133b inhibits hepatocellular carcinoma cell progression by targeting Sirt1.
    Tian Z; Jiang H; Liu Y; Huang Y; Xiong X; Wu H; Dai X
    Exp Cell Res; 2016 May; 343(2):135-147. PubMed ID: 27090017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SIRT1 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma and its expression predicts poor prognosis.
    Chen HC; Jeng YM; Yuan RH; Hsu HC; Chen YL
    Ann Surg Oncol; 2012 Jun; 19(6):2011-9. PubMed ID: 22146883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitric oxide inhibits FTO demethylase activity to regulate N
    Kuschman HP; Palczewski MB; Hoffman B; Menhart M; Wang X; Glynn S; Islam ABMMK; Benevolenskaya EV; Thomas DD
    Redox Biol; 2023 Nov; 67():102928. PubMed ID: 37866163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of SIRT1 promotes metastasis through epithelial-mesenchymal transition in hepatocellular carcinoma.
    Hao C; Zhu PX; Yang X; Han ZP; Jiang JH; Zong C; Zhang XG; Liu WT; Zhao QD; Fan TT; Zhang L; Wei LX
    BMC Cancer; 2014 Dec; 14():978. PubMed ID: 25522783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential m
    Wei J; Liu F; Lu Z; Fei Q; Ai Y; He PC; Shi H; Cui X; Su R; Klungland A; Jia G; Chen J; He C
    Mol Cell; 2018 Sep; 71(6):973-985.e5. PubMed ID: 30197295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss-of-Function Genetic Screening Identifies Aldolase A as an Essential Driver for Liver Cancer Cell Growth Under Hypoxia.
    Niu Y; Lin Z; Wan A; Sun L; Yan S; Liang H; Zhan S; Chen D; Bu X; Liu P; Chen C; He W; Lu X; Wan G
    Hepatology; 2021 Sep; 74(3):1461-1479. PubMed ID: 33813748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. m
    Cui Q; Shi H; Ye P; Li L; Qu Q; Sun G; Sun G; Lu Z; Huang Y; Yang CG; Riggs AD; He C; Shi Y
    Cell Rep; 2017 Mar; 18(11):2622-2634. PubMed ID: 28297667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ALKBH5 suppresses malignancy of hepatocellular carcinoma via m
    Chen Y; Zhao Y; Chen J; Peng C; Zhang Y; Tong R; Cheng Q; Yang B; Feng X; Lu Y; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2020 Aug; 19(1):123. PubMed ID: 32772918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FTO Demethylates Cyclin D1 mRNA and Controls Cell-Cycle Progression.
    Hirayama M; Wei FY; Chujo T; Oki S; Yakita M; Kobayashi D; Araki N; Takahashi N; Yoshida R; Nakayama H; Tomizawa K
    Cell Rep; 2020 Apr; 31(1):107464. PubMed ID: 32268083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FTO in cancer: functions, molecular mechanisms, and therapeutic implications.
    Li Y; Su R; Deng X; Chen Y; Chen J
    Trends Cancer; 2022 Jul; 8(7):598-614. PubMed ID: 35346615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NADP modulates RNA m
    Wang L; Song C; Wang N; Li S; Liu Q; Sun Z; Wang K; Yu SC; Yang Q
    Nat Chem Biol; 2020 Dec; 16(12):1394-1402. PubMed ID: 32719557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNA N6-methyladenosine demethylase FTO promotes pancreatic cancer progression by inducing the autocrine activity of PDGFC in an m
    Tan Z; Shi S; Xu J; Liu X; Lei Y; Zhang B; Hua J; Meng Q; Wang W; Yu X; Liang C
    Oncogene; 2022 May; 41(20):2860-2872. PubMed ID: 35422475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of N
    Deng X; Su R; Feng X; Wei M; Chen J
    Curr Opin Genet Dev; 2018 Feb; 48():1-7. PubMed ID: 29040886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemical Inhibitors Targeting the Oncogenic m
    Huang Y; Xia W; Dong Z; Yang CG
    Acc Chem Res; 2023 Nov; 56(21):3010-3022. PubMed ID: 37889223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FTO: An Emerging Molecular Player in Neuropsychiatric Diseases.
    Annapoorna PK; Iyer H; Parnaik T; Narasimhan H; Bhattacharya A; Kumar A
    Neuroscience; 2019 Oct; 418():15-24. PubMed ID: 31442565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.